Table 4.
Duration of Treatment-Associated AEs
| Treatment-associated AEs | Duration, HA filling plus mesotherapy combined treatment group (days) | Duration, BTX-A treatment group (days) | P value |
|---|---|---|---|
| Lumps | 99 [14.1] | — | — |
| Erythema | 10.9 [1.7] | 4.4 [0.9] | 0.000 |
| Topical edema and swelling | 10.7 [1.3] | 2.5 [0.7] | 0.000 |
| Ecchymosis | 12.2 [1.1] | 10.3 [0.8] | 0.001 |
| Tyndall effect | 102.5 [9.2] | — | — |
| Trachyphonia | — | 35 | — |
| Rashes and itchiness | 12.7 [2.1] | — | — |
Values are mean [standard deviation]. AE, adverse event; BTX-A, botulinum toxin A; HA, hyaluronic acid.